<doc>
  <docmeta id="113hr4709ih">
    <bill congress="113" type="hr" number="4709" version="ih"/>
    <revision size="5900" annotations="0" status="complete" id="3" commit-time="2014-05-27T16:53:47Z" committer="mbohmer" doc="113hr4709ih/3.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HEA367D0501F54DFE8B821C161D1C78A9" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 4709 IH: Ensuring Patient Access and Effective Drug Enforcement Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-05-21</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 4709</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20140521">May 21, 2014</action-date>
			<action-desc>
        <sponsor name-id="M001179">Mr. Marino</sponsor> (for himself, <cosponsor name-id="B001243">Mrs. Blackburn</cosponsor>, <cosponsor name-id="W000800">Mr. Welch</cosponsor>, and <cosponsor name-id="C001080">Ms. Chu</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on the <committee-name committee-id="HJU00">Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To improve enforcement efforts related to prescription drug diversion and abuse, and for other
			 purposes.</official-title>
	</form>
	<legis-body id="HAEF97E493D1940C693F84A1B5D02C1F7" style="OLC">
		<section id="H1A3C234A6A3F4180915AF86882056194" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Ensuring Patient Access and Effective Drug Enforcement Act of 2014" proposed="true">Ensuring Patient Access and Effective Drug Enforcement Act of 2014</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section id="H4060093F474B4460B925E04FF2CDB367">
      <enum>2.</enum>
      <header>Registration process under Controlled Substances Act</header>
			<subsection id="H4EB98953CE494279B2FD203A93FFEFC7">
        <enum>(a)</enum>
        <header>Definitions</header>
				<paragraph id="H0370E1D6A08C47EDB9469C9E40E80F5F">
          <enum>(1)</enum>
          <header>Consistent with the public health and safety</header>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:303">Section 303 of the Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/823">
                <cato:entity-ref entity-type="uscode" value="usc/21/823">21 U.S.C. 823</cato:entity-ref>
              </external-xref>)</cato:entity> is amended by adding at the end the
			 following:</text>
					<quoted-block display-inline="no-display-inline" id="HC23ABE5D37C8466EAE9E17D77747E71E" style="OLC">
						<subsection id="HE28889F9321B4D70A71D108F4ABE5AC8">
              <enum>(j)</enum>
              <text display-inline="yes-display-inline">In this section, the phrase <quote>consistent with the public health and safety</quote> means having a substantial relationship to this Act’s purpose of preventing diversion and abuse of
			 controlled substances.</text>
            </subsection>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
        <paragraph id="H443A13BAB1724614B4ECAFDCE19ECCD8">
          <enum>(2)</enum>
          <header>Imminent danger</header>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:304/ss:d">Section 304(d) of the Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/824">
                <cato:entity-ref entity-type="uscode" value="usc/21/824/d">21 U.S.C. 824(d)</cato:entity-ref>
              </external-xref>)</cato:entity> is amended—</text>
					<subparagraph id="H037E8677CDEE4ABBAB3BA33818469E4E">
            <enum>(A)</enum>
            <text>by striking <quote>(d) The Attorney General</quote> and inserting <quote>(d)(1) The Attorney General</quote>; and</text>
					</subparagraph>
          <subparagraph id="HBF5766243F734476A119A6AFE9AA7584">
            <enum>(B)</enum>
            <text>by adding at the end the following:</text>
						<quoted-block display-inline="no-display-inline" id="HED80E5E3A6764205894F08031973576D" style="OLC">
							<paragraph id="H6592CF50EB9D496AB6E7B49DC0D781B3" indent="up1">
                <enum>(2)</enum>
                <text display-inline="yes-display-inline">In this subsection, the term <term>imminent danger</term> means a significant and present risk of death or serious bodily harm that is more likely than not
			 to occur in the absence of an immediate suspension order.</text>
              </paragraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</subparagraph>
        </paragraph>
      </subsection>
      <subsection id="H01AF43FDA0544A5891C84C2D41E0F74B">
        <enum>(b)</enum>
        <header>Opportunity To submit corrective action plan prior to revocation or suspension</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:304/ss:c">Section 304(c) of the Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/824">
              <cato:entity-ref entity-type="uscode" value="usc/21/824/c">21 U.S.C. 824(c)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended—</text>
				<paragraph id="H956C0DD8D9ED4FD19550497D8856FF6A">
          <enum>(1)</enum>
          <text>by striking <quote>(c) Before</quote> and inserting <quote>(c)(1) Before</quote>; and</text>
				</paragraph>
        <paragraph id="H220F20C5379948E6A45770A8E42E1FFD">
          <enum>(2)</enum>
          <text>by adding at the end the following:</text>
					<quoted-block display-inline="no-display-inline" id="H6AC7CBF4B286487BB12E6DB4518CA348" style="OLC">
						<paragraph id="HF219B3BF3994423FB7475743E97DBE98" indent="up1">
              <enum>(2)</enum>
              <text display-inline="yes-display-inline">Before revoking or suspending a registration pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303">section 303</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1500">Attorney General</cato:entity-ref> shall—</text>
							<subparagraph id="H84E80B237D604876A695192524179377">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">provide—</text>
								<clause id="H9C396F22141D4DD68423451F80345B6F">
                  <enum>(i)</enum>
                  <text>notice to the registrant of the grounds for revocation or suspension; and</text>
								</clause>
                <clause id="HE801358AE73945C7B04DC956526E2979">
                  <enum>(ii)</enum>
                  <text>in the case of any such grounds consisting of a violation of law, a specific citation to such law;</text>
								</clause>
              </subparagraph>
              <subparagraph id="H80D6EE276EAF4F208ED63B5BDFB12E7E">
                <enum>(B)</enum>
                <text>give the registrant an opportunity to submit a corrective action plan within a reasonable period of
			 time to demonstrate how the registrant plans to correct the grounds for
			 revocation or suspension; and</text>
							</subparagraph>
              <subparagraph id="HFA7822B206BF4CDE81D4806C3EFA14A1">
                <enum>(C)</enum>
                <text>determine whether—</text>
								<clause id="H378CE9AA98CC45FBB1F79B1083F44D25">
                  <enum>(i)</enum>
                  <text>in light of the plan, revocation or suspension proceedings should be discontinued or deferred; or</text>
								</clause>
                <clause id="H86DB9FE2BC64447C973EA4C2BE887B25">
                  <enum>(ii)</enum>
                  <text>additional changes need to be made in the corrective action plan.</text>
                </clause>
              </subparagraph>
            </paragraph>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </subsection>
    </section>
    <section id="HCEC36C4C60924DCA81E8A1F4CF6A15ED">
      <enum>3.</enum>
      <header>Report to Congress on effects of law enforcement activities on patient access to medications</header>
			<subsection id="H1FC368A2150A4B75A00B35564B3B3EA5">
        <enum>(a)</enum>
        <header>In general</header>
        <text display-inline="yes-display-inline">Not later than one year after the date of enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human
			 Services</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner of Food and Drugs</cato:entity-ref> and the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease Control and Prevention</cato:entity-ref>, and in
			 consultation with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1524">Administrator of the Drug Enforcement Administration</cato:entity-ref>
			 and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1127">Director of National Drug Control Policy</cato:entity-ref>, shall submit a report to
			 the Congress—</text>
				<paragraph id="H1EA96BC8B3C849B194E82FF66FAC86D9">
          <enum>(1)</enum>
          <text>assessing how patient access to medications could be adversely impacted by Federal and State law
			 enforcement activities; and</text>
				</paragraph>
        <paragraph id="H97341524A9394C228233DE5C3E94A9F4">
          <enum>(2)</enum>
          <text>identifying how collaboration between agencies and stakeholders can benefit patients and prevent
			 diversion and abuse of controlled substances.</text>
				</paragraph>
      </subsection>
      <subsection id="HFC2A3FC57C8B43E9A761B737B4BA19E1">
        <enum>(b)</enum>
        <header>Consultation</header>
        <text display-inline="yes-display-inline">The report under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Ensuring Patient Access and Effective Drug Enforcement Act of 2014/s:3/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall incorporate feedback and recommendations from the following:</text>
				<paragraph id="H94C2CFF0AB8F4E5DB9276D016E6B9727">
          <enum>(1)</enum>
          <text>Patient groups.</text>
				</paragraph>
        <paragraph id="HD5B2D934E0B94E2DBE024AF816BEBD70">
          <enum>(2)</enum>
          <text>Pharmacies.</text>
				</paragraph>
        <paragraph id="H6EA61D081A79404F9116785DC1DA7449">
          <enum>(3)</enum>
          <text>Manufacturers of drugs.</text>
				</paragraph>
        <paragraph id="H8C70C2F24CE24B5A91AB1ED0B99C9806">
          <enum>(4)</enum>
          <text>Common or contract carriers and warehousemen.</text>
				</paragraph>
        <paragraph id="HE71DBCE805E14D23A1EBDF3D4DF06209">
          <enum>(5)</enum>
          <text>Hospitals, physicians, and other health care providers.</text>
				</paragraph>
        <paragraph id="H22777373DAD84350BA84457C14F5EE00">
          <enum>(6)</enum>
          <text>State attorneys general.</text>
				</paragraph>
        <paragraph id="H491EB40AA18F4A76B6BACEF67FD1690F">
          <enum>(7)</enum>
          <text>Law enforcement officials, including local law enforcement officials.</text>
				</paragraph>
        <paragraph id="H3C55551E65F3487DB77033BBC119FFA7">
          <enum>(8)</enum>
          <text>Health benefit plans and entities that provide pharmacy benefit management services on behalf of a
			 health benefit plan.</text>
				</paragraph>
        <paragraph id="H58AFF0710FC943F48919AB6E2D259531">
          <enum>(9)</enum>
          <text>Wholesale drug distributors.</text>
				</paragraph>
      </subsection>
    </section>
  </legis-body>
</bill>
</doc>